ATRC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
153.6M
+8.7%
141.2M
+0.5%
140.5M
+4.6%
134.3M
-1.4%
136.1M
Cost of Revenue
35.0M
+9.5%
31.9M
-9.2%
35.2M
+6.8%
32.9M
-5.0%
34.7M
Gross Profit
118.6M
+8.5%
109.3M
+3.8%
105.3M
+4.0%
101.3M
-0.1%
101.5M
Operating Expenses
109.0M
+0.2%
108.8M
+5.8%
102.8M
+1.7%
101.1M
-6.1%
107.7M
R&D
26.4M
+8.9%
24.2M
-1.1%
24.5M
+7.0%
22.9M
-21.8%
29.3M
SG&A
82.6M
-2.4%
84.5M
+7.9%
78.3M
+0.1%
78.2M
-0.2%
78.4M
Operating Income
9.7M
+1737.5%
526.0K
-78.9%
2.5M
+1097.6%
208.0K
+103.4%
-6192000
EBITDA
15.0M
+158.2%
5.8M
-23.7%
7.6M
+41.3%
5.4M
+626.6%
-1021000
Net Income
9.0M
+8191.7%
108.0K
-93.8%
1.8M
+757.7%
-267000
+95.7%
-6190000
EPS (Basic)
$0.18
$0.00
-100.0%
$0.04
+500.0%
$-0.01
+92.3%
$-0.13
EPS (Diluted)
$0.18
$0.00
-100.0%
$0.04
+500.0%
$-0.01
+92.3%
$-0.13
Shares (Diluted)
48.9M
-0.4%
49.0M
+2.3%
48.0M
+0.1%
47.9M
+0.4%
47.7M
AtriCure (ATRC) โ€” Financials